-
Human biology thankfully allows us to adapt to major changes in temperature, but only so quickly. Professor Cara Ocobock is working with reindeer herders in subarctic Finland to find out how the human body evolved to withstand the extreme cold over time. What can we learn from communities that have a long history of living and working in the frigid weather?
-
A new “Jurassic Park” movie is coming out next year, the latest installment of the blockbuster series all about the dangerous hubris in trying to bring dinosaurs back from extinction. Paleogeneticist Beth Shapiro says the science may be flawed, but cloning extinct species is more realistic than you may think. In fact, that work is already underway — but with the slightly friendlier woolly mammoth.
-
Missouri quietly restricted its policy for transgender residents to change the gender markers on their state IDs. For some people, it was the last straw. Plus: How Children’s Mercy researchers are working to make genetic testing more accessible in rural Kansas.
-
Rare diseases are hard to diagnose and often require costly genetic testing and visits to specialists. The testing can be hard to access, especially for people who live in rural areas. Researchers at the Genomic Medicine Center at Children’s Mercy Kansas City are trying to close the gap.
-
We tend to think of getting older as inevitable, but what if it’s actually something we can control? Researchers like David Sinclair and Nir Barzilai have discovered some of the secrets to reversing aging, found animals who defy our understandings of life, and turned old mice young again. But even if humans could live forever, should we?
-
In January, a Parkville family learned their 8-year-old daughter had a rare illness. Though there is no cure, there is a drug that could help slow the disease. The problem? It costs more than $200,000 a year. Plus: Kansas politicians make bold claims about how to stop population declines in rural communities. Their efforts may not be enough to reverse the trend.
-
In January, the Anstaett family learned their eight-year-old daughter had Batten disease, a rare condition with a difficult — and eventually terminal — prognosis. The drug showing promise in slowing the disease isn't covered by their insurance because it's still in clinical trials.
-
20 years after scientists finished the sequencing of the first human genome, scientists around the world — including from the Stowers Institute in Kansas City — have taken another monumental step.
-
We tend to think of getting older as inevitable, but what if it’s actually something we can control? Researchers like David Sinclair and Nir Barzilai have discovered some of the secrets to reversing aging, found animals who defy our understandings of life, and turned old mice young again. But even if humans could live forever, should we?
-
We tend to think of getting older as inevitable, but what if it’s actually something we can control? Researchers like David Sinclair and Nir Barzilai have discovered some of the secrets to reversing aging, found animals who defy our understandings of life, and turned old mice young again. But even if humans could live forever, should we?
-
Donavon Decker became, in more ways than one, an ambassador of limb girdle muscular dystrophy type 2D, a rare degenerative disorder. But decades after he participated in patient trials and fundraised for research, drug companies are still nowhere close to a cure.
-
"Origin: A Genetic History of the Americas" by Jennifer Raff uses DNA evidence to tell how the first peoples came to the Americas.